Literature DB >> 2357704

Management of Gilles de la Tourette syndrome using sulpiride.

M M Robertson1, V Schnieden, A J Lees.   

Abstract

One hundred and fourteen patients with Gilles de la Tourette syndrome have been reviewed. Sixty-three were managed using sulpiride, and worthwhile beneficial effects occurred in 59%. Our experience with sulpiride compared to other drug treatments is discussed. The main adverse side effects of sulpiride treatment were sustained drowsiness and, possibly, depression. Tardive dyskinesia was not reported in our cohort.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357704     DOI: 10.1097/00002826-199006000-00005

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  18 in total

Review 1.  Emerging treatments for Tourette's disorder.

Authors:  Michael H Bloch
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

Review 2.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 3.  [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

Authors:  K R Müller-Vahl
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

4.  Treatment of tics and tourette syndrome.

Authors:  Harvey S Singer
Journal:  Curr Treat Options Neurol       Date:  2010-11       Impact factor: 3.598

5.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

6.  Tourette syndrome and other tic disorders in childhood, adolescence and adulthood.

Authors:  Andrea G Ludolph; Veit Roessner; Alexander Münchau; Kirsten Müller-Vahl
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

Review 7.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 8.  Behavior therapy in tic-disorders with co-existing ADHD.

Authors:  Manfred Döpfner; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

Review 9.  Contemporary assessment and pharmacotherapy of Tourette syndrome.

Authors:  Lawrence Scahill; Gerald Erenberg; Cheston M Berlin; Cathy Budman; Barbara J Coffey; Joseph Jankovic; Louise Kiessling; Robert A King; Roger Kurlan; Anthony Lang; Jonathan Mink; Tanya Murphy; Samual Zinner; John Walkup
Journal:  NeuroRx       Date:  2006-04

Review 10.  The pharmacology of Tourette syndrome.

Authors:  Roji Thomas; Andrea E Cavanna
Journal:  J Neural Transm (Vienna)       Date:  2013-01-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.